CLINICAL TRIALS PROFILE FOR CHIGLITAZAR
✉ Email this page to a colleague
Clinical Trials for Chiglitazar
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT02121717 ↗ | Study of Chiglitazar Compare With Placebo in Type 2 Diabetes Patients | Completed | Chipscreen Biosciences, Ltd. | Phase 3 | The purpose of this study is to evaluate the efficacy and safety of Chiglitazar, compare with placebo. |
NCT02173457 ↗ | Study of Chiglitazar Compare With Sitagliptin in Type 2 Diabetes Patients | Completed | Chipscreen Biosciences, Ltd. | Phase 3 | The purpose of this study is to evaluate the efficacy and safety of Chiglitazar, compare with Sitagliptin. |
NCT04807348 ↗ | Chiglitazar Added to Metformin for Type 2 Diabetes | Recruiting | Chipscreen Biosciences, Ltd. | Phase 3 | The purpose of the trial is to evaluate the effect of Chiglitazar added to metformin to type 2 diabetes Inadequately controlled with metformin Monotherapy. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for Chiglitazar
Condition Name
Clinical Trial Locations for Chiglitazar
Clinical Trial Progress for Chiglitazar
Clinical Trial Phase
Clinical Trial Sponsors for Chiglitazar
Sponsor Name